DAFNA Capital Management manages investments for private investment funds. DAFNA specializes in analyzing companies in the life science field. DAFNA evaluates investments based on events that could affect a company's stock price, such as clinical trial results and regulatory decisions. The firm's investment strategies involve both long and short positions, primarily in biotechnology and medical device companies.
DAFNA Capital Management manages investments for private investment funds and receives an annual management fee based on the account balance of each fund investor. DAFNA also receives an annual performance-based fee based on the net capital appreciation of each investor’s account in the fund. DAFNA may waive or reduce the management fee or performance-based fee for any or all investors.